Skip to main content
. 2019 Jan 4;17(3):2874–2880. doi: 10.3892/ol.2019.9894

Table II.

Comparison of clinical efficacy between two groups of patients [n (%)].

Group n CR PR SD PD Effective rate Tumor local control rate
Experimental group 67 16 (23.88) 39 (58.21) 7 (10.45) 5 (7.46) 82.09% 92.54%
Control group 53 13 (24.53) 20 (37.74) 9 (16.98) 11 (20.75) 62.26% 79.25%
χ2 5.948 4.524
P-value <0.05 <0.05

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.